17β-estradiol up-regulates endothelial nitric oxide synthase (eNOS) expression in cultured endothelial cells. To clarify the role of mRNA stabilization in upregulation of eNOS expression, endothelial cells were incubated with actinomycin D as transcriptional inhibitor. Up to 10 hours incubation with 17β-estradiol alone did not affect significantly the stability of eNOS mRNA. As tumor necrosis factor-α (TNF-α) is associated with the progression of atherosclerosis, we examined the effect of 17β-estradiol on eNOS mRNA destabilization with TNF-α. After 10 hours co-incubation with TNF-α, relative intensity of eNOS mRNA decreased to 50% of the intensity at the start time of incubation, however, it remained significantly 1.6 times in the presence of 17β-estradiol. This inhibitory effect of 17β-estradiol was abolished by the treatment of estrogen receptor antagonist, ICI 182,780. This is the first finding that 17β-estradiol stabilizes eNOS mRNA destabilized by TNF-α through estrogen receptor mediated mechanism.
|Original language||English (US)|
|Number of pages||10|
|State||Published - Aug 24 2001|
- Endothelial nitric oxide synthase
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology, Toxicology and Pharmaceutics(all)